Clinical trial
qDSA Blood Flow Measurement in Patients Undergoing Transarterial Embolization (TAE) of the Liver
NCT06971991 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- qDSA Blood Flow Measurement in Patients Undergoing Transarterial Embolization (TAE) of the Liver
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 13, 2025
- Completion date
- December 31, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
radioembolization, transarterial chemoembolization, transarterial embolism